U.S. District Court Judge David H. Coar has denied Abbott’s request for a temporary restraining order to block generic sales of Biaxin XL by Sandoz, the Novartis generic arm. Sandoz began selling generic Biaxin XL on December 04. Abbott claims that the Sandoz version infringes three patents, including one for an extended release version of the compound clarithromycin.
No comments:
Post a Comment